Sars-Cov-2 Spike Glycoprotein S1 (Derived from SF9 cell line)
Shipping Info:
For estimated delivery dates, please contact us at support@abeomics.com
| Amount : | 50 µg |
| Purification : | Protein is >85% pure as determined SDS-PAGE. |
| Content : | CoV-2 S1 protein solution is supplied in DPBS. |
| Storage condition : | Store at -20°C. |
| AA sequence : | The Sf9 derived recombinant protein contains the Coronavirus 2019 CoV-2 Spike Glycoprotein S1, Wuhan-Hu-1 strain, amino acids 1-674 fused to His tag at C-terminal. |
| Alternative Name : | Coronavirus 2019 CoV-2 Spike Glycoprotein S1 (SF9 cell line) |
Source: Sf9, derived from Sf9 cells. A human infecting coronavirus (viral pneumonia) called 2019 novel coronavirus, 2019-nCoV was found in the fish market at the city of Wuhan, Hubei province of China on December 2019. The 2019-nCoV shares an 87% identity to the 2 bat-derived severe acute respiratory syndrome 2018 SARS-CoV-2 located in Zhoushan of eastern China. 2019-nCoV has an analogous receptor-BD-structure to that of 2018 SARS-CoV, even though there is a.a. diversity so thus the 2019-nCoV might bind to ACE2 receptor protein (angiotensin-converting enzyme 2) in humans. While bats are possibly the host of 2019-nCoV, researchers suspect that animal from the ocean sold at the seafood market was an intermediate host. RSCU analysis proposes that the 2019-nCoV is a recombinant within the viral spike glycoprotein between the bat coronavirus and an unknown coronavirus.
|
There are currently no product reviews
|
